PARVOVIRUS B 19 - ANVISA Registration 10339840548
Access comprehensive regulatory information for PARVOVIRUS B 19 in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10339840548 and manufactured by manufacturer not specified. The registration is held by DIASORIN LTDA with validity until Oct 23, 2033.
This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including DIASORIN ITALIA S.P.A., DIASORIN MOLECULAR LLC, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Related Devices (2)
Registration Details
10339840548
25351454288202384
01896764000170
Company Information
Dates and Status
Oct 23, 2023
23/10/2033
09/18/2025 19:00:01
PARVOVÍRUS B 19
Família Parvovirus B19 Run Control
EXACT DIAGNOSTICS
80020690439
Jan 27, 2025
PARVOVÍRUS B 19
Família Parvovirus B19 Run Control
Not specified
80020690439
Jan 27, 2025
PARVOVÍRUS B 19
Família LIAISON® Biotrin Parvovírus B19 IgG Plus
Not specified
10339840547
Oct 23, 2023
PARVOVÍRUS B 19
Família LIAISON® Biotrin Parvovírus B19 IgG Plus
DIASORIN ITÁLIA S.P.A
10339840547
Oct 23, 2023
PARVOVÍRUS B 19
Parvovirus Virclia IgG Monotest
Not specified
10259610247
Mar 27, 2023

